BIO
Bio-Rad Laboratories, Inc.
NYSEUSDEQUITY
DELAYED
Last price
380.03
▲ 3.57 (0.95%)
MARKET · —
Price
Open
381.35
Prev close
376.46
Day high
385.92
Day low
373.47
Volume
302.71K
Market cap
—
P/E (TTM)
—
52W range
236.73 – 385.92
Trailing performance
Returnvs SPY
1W
+6.67%
+8.0%
1M
+20.12%
+16.4%
3M
+32.53%
+29.4%
6M
+40.08%
+29.0%
YTD
+25.43%
+13.1%
1Y
+31.88%
+11.9%
3Y
-1.66%
-75.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
361.90
+5.01% from price
SMA 20
347.81
+9.26% from price
SMA 50
315.93
+20.29% from price
SMA 100
299.17
+27.03% from price
SMA 200
298.24
+27.43% from price
EMA 12
358.90
+5.89% from price
EMA 26
342.60
+10.93% from price
EMA 50
325.45
+16.77% from price
RSI (14)
77.8
Overbought
MACD (12,26,9)
16.30
Hist 1.55
ATR (14)
12.10
3.18% of price
Realised vol 30D
27.1%
Annualised
Bollinger upper
382.04
20, 2σ
Bollinger lower
313.58
20, 2σ
50 / 200 cross
Golden
315.93 vs 298.24
Trend bias
Above 200
+27.43%
Risk profile
Beta vs SPY
0.80
Less volatile than market
Correlation to SPY
0.27
Largely independent
Realised vol 30D
27.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-28.9%
Peak to trough
Max drawdown 5Y
-73.8%
Peak to trough
ATR 14
12.10
3.18% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?
Zacks · 22h ago
Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building?
Zacks · 2d ago
Could Danaher Corporation (DHR)’s Bioprocessing Recovery Give Bio-Rad Laboratories (BIO) Stock a Boost?
Insider Monkey · 9d ago
Bio-Rad (BIO) Q2 2026 Earnings Call Transcript
Motley Fool · 11d ago
IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
GlobeNewswire · 12d ago
Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock
Zacks · 12d ago
Bio Rad Laboratories (BIO) Earnings And Guidance Put Fair Value Back In Focus
Simply Wall St. · 13d ago
Biocon (NSEI:BIOCON) Stock Gets Fair Value Bump On Margin Focus And Peer Valuation Cues
Simply Wall St. · 13d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.